ISRCTN67900293进行中（未招募）未知
A multi-centre, pragmatic, randomised controlled trial of comparing enhanced Acceptance and Commitment Therapy (plus) added to usual aftercare, versus usual aftercare only
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 344
研究概览
简要总结
2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38566197/ (added 03/04/2024)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Current inclusion criteria as of 28/11/2023:
- •1. Within 24 months of having completed cancer treatment, (or about to complete) with curative intent for breast cancer, lower gastro-intestinal cancer, urological cancer, a haematological cancer, head and neck cancer, and any other common cancer with good survival
- •2. Aged 18 years or over
- •3. Participant’s GP practice falls within a participating IAPT service catchment, or if other psychological service provider, participant resides within their catchment area
- •4. Ability to give informed consent
- •5. Sufficient fluency in spoken English to be able to participate in a talking-based therapy delivered in English
- •6. With a score of 78 or less on the Functional Assessment of Cancer Therapy – General (FACT-G)
- •Previous inclusion criteria:
- •1. Within 24 months of having completed cancer treatment, (or about to complete) with curative intent for breast cancer, colorectal cancer, prostate cancer, a haematological cancer, head and neck cancer, and any other common cancer with good survival
- •2. Aged 18 years or over
- •3. Participant’s GP practice falls within a participating IAPT service catchment, or if other psychological service provider, participant resides within their catchment area
- •4. Ability to give informed consent
- •5. Sufficient fluency in spoken English to be able to participate in a talking-based therapy delivered in English
- •6. With a score of 78 or less on the Functional Assessment of Cancer Therapy – General (FACT-G)
排除标准
- •Current exclusion criteria as of 28/11/2023:
- •1. Will not have not completed their cancer treatment by the commencement of the trial (excepting those receiving long-term, ongoing maintenance treatment e.g. androgen suppression therapy in urological cancer)
- •2. Receiving palliative or terminal care
- •3. Currently receiving another psychological intervention (NB participants taking antidepressants or anxiolytic drugs remain eligible)
- •4. Other serious co-morbid condition which would make it difficult for the participant to receive a talking-based one-to one intervention
- •5. Require urgent psychiatric or clinical psychology assessment
- •Previous exclusion criteria:
- •1. Will not have not completed their cancer treatment by the commencement of the trial (excepting those receiving long-term, ongoing maintenance treatment e.g. androgen suppression therapy in prostate cancer)
- •2. Receiving palliative or terminal care
- •3. Currently receiving another psychological intervention (NB participants taking antidepressants or anxiolytic drugs remain eligible)
- •4. Other serious co-morbid condition which would make it difficult for the participant to receive a talking-based one-to one intervention
- •5. Require urgent psychiatric or clinical psychology assessment
研究者
相似试验
进行中（未招募）
Unknown
Rehabkompassen® – A digital structured follow-up tool for facilitating patient-tailored rehabilitation in persons after strokeNervous System DiseasesStrokeISRCTN63166587Region Västerbotten1,106
进行中（未招募）
Unknown
A study regarding rest, recreation and spending time outdoors as support for health and well-being of young cancer survivorsISRCTN93856392Mid Sweden University150
进行中（未招募）
不适用
Autologous stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing-remitting multiple sclerosisMultiple sclerosisRelapsing-remitting multiple sclerosisNervous System DiseasesISRCTN88667898Sheffield Teaching Hospitals NHS Foundation Trust198
已完成
不适用
Health professional Administered Brief Insomnia Therapy (HABIT) trialMental and Behavioural DisordersDisorders of initiating and maintaining sleep [insomnias]InsomniaISRCTN42499563niversity of Oxford642
进行中（未招募）
不适用
A parallel multi-centre randomised controlled trial to determine the clinical and cost-effectiveness of DREAMS START (Dementia RElAted Manual for Sleep; STrAtegies for RelaTives) for people living with dementia and their carersISRCTN13072268Camden and Islington NHS Foundation Trust740